Long Term Effect of High Glucose and Phosphate Levels on the OPG/RANK/RANKL/TRAIL System in the Progression of Vascular Calcification in rat Aortic Smooth Muscle Cells

被引:20
作者
Kang, Yang Ho [1 ,2 ,3 ,4 ]
Jin, Jung Sook [2 ]
Son, Seok Man [1 ,2 ,3 ,4 ]
机构
[1] Pusan Natl Univ, Sch Med, Div Endocrinol & Metab, Dept Internal Med, Yangsan 626770, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, South Korea
[3] Pusan Natl Univ, Yangsan Hosp, Ctr Diabet, Yangsan 626770, South Korea
[4] Pusan Natl Univ, Yangsan Hosp, Endocrine Clin, Yangsan 626770, South Korea
关键词
High glucose; Osteoprotegerin; Phosphate; TNF-related apoptosis-inducing ligand; Vascular calcification; BONE MORPHOGENETIC PROTEIN-7; TYPE-2; DIABETIC-PATIENTS; KAPPA-B LIGAND; IN-VITRO; ARTERIAL CALCIFICATION; CLINICAL-IMPLICATIONS; ALKALINE-PHOSPHATASE; RECEPTOR ACTIVATOR; TRAIL EXPRESSION; VITAMIN-D;
D O I
10.4196/kjpp.2015.19.2.111
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Osteoprotegerin (OPG), receptor activator of NF- kappa B ligand (RANKL)/receptor activator of NF- kappa B (RANK) axis, and TNF-related apoptosis-inducing ligand (TRAIL) participate in vascular calcification process including atherosclerosis, but their contributions under high glucose (HG) and phosphate (HP) condition for a long-term period (more than 2 weeks) have not been fully determined. In this study, we evaluated the effects of HG and HP levels over 2 or 4 weeks on the progression of vascular calcification in rat vascular smooth muscle cells (VSMCs). Calcium deposition in VSMCs was increased in medium containing HG (30 mmol/L D-glucose) with beta -glycerophosphate (beta -GP, 12 mmol/L) after 2 weeks and increased further after 4 weeks. OPG mRNA and protein expressions were unchanged in HG group with or without beta -GP after 2 weeks. However, after 4 weeks, OPG mRNA and protein expressions were significantly lower in HG group with beta -GP. No significant expression changes were observed in RANKL, RANK, or TRAIL during the experiment. After 4 weeks of treatment in HG group containing beta -GP and rhBMP-7, an inhibitor of vascular calcification, OPG expressions were maintained. Furthermore, mRNA expression of alkaline phosphatase (ALP), a marker of vascular mineralization, was lower in the presence of rhBMP-7. These results suggest that low OPG levels after long term HG and phosphate stimulation might reduce the binding of OPG to RANKL and TRAIL, and these changes could increase osteo-inductive VSMC differentiation, especially vascular mineralization reflected by increased ALP activity during vascular calcification.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 47 条
[1]
Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) in heterotopic vascular ossification [J].
Al-Fakhri, N ;
Hofbauer, LC ;
Preissner, KT ;
Franke, FE ;
Schoppet, M .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (06) :1335-1337
[2]
Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[3]
Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients [J].
Avignon, A ;
Sultan, A ;
Piot, C ;
Elaerts, S ;
Cristol, JP ;
Dupuy, AM .
DIABETES CARE, 2005, 28 (09) :2176-2180
[4]
Boström KI, 2000, Z KARDIOL, V89, P69
[5]
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo [J].
Candido, Riccardo ;
Toffoli, Barbara ;
Corallini, Federica ;
Bernardi, Stella ;
Zella, Davide ;
Voltan, Rebecca ;
Grill, Vittorio ;
Celeghini, Claudio ;
Fabris, Bruno .
JOURNAL OF VASCULAR RESEARCH, 2010, 47 (03) :252-261
[6]
High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells [J].
Chen, Neal X. ;
Duan, Danxia ;
O'Neill, Kalisha D. ;
Moe, Sharon M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (12) :3435-3442
[7]
Arterial calcification in diabetes [J].
Chen N.X. ;
Moe S.M. .
Current Diabetes Reports, 2003, 3 (1) :28-32
[8]
Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells [J].
Chen, NX ;
O'Neill, KD ;
Duan, D ;
Moe, SM .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1724-1731
[9]
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin [J].
Collin-Osdoby, P .
CIRCULATION RESEARCH, 2004, 95 (11) :1046-1057
[10]
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro [J].
Corallini, Federica ;
Celeghini, Claudio ;
Rizzardi, Clara ;
Pandolfi, Assunta ;
Di Silvestre, Sara ;
Vaccarezza, Mauro ;
Zauli, Giorgio .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (01) :89-95